Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Nov 20;59(11):2041.
doi: 10.3390/medicina59112041.

Clinical Outcomes of Percutaneous Left-Atrial Appendage Occlusion with Conscious Sedation without an Anesthesiologist on Site: Results from a Multicenter Study

Matteo Bianco  1 , Andrea Carmelo Visalli  1 , Francesco Tomassini  2 , Carloalberto Biolè  1 , Federico Giacobbe  1 , Cristina Rolfo  2 , Enrico Cerrato  2 , Alfonso Franzè  2 , Greca Zanda  2 , Marco Pavani  2 , Amir Hassan Mousavi  1 , Giulia Gobello  1 , Giulio Piedimonte  2 , Paola Destefanis  1 , Maurizio Lazzero  1 , Sara Palacio Restrepo  3 , Dario Celentani  3 , Alessia Luciano  1 , Emanuele Tizzani  3 , Alessandra Chinaglia  1 , Ferdinando Varbella  2   3
Affiliations
Multicenter Study

Clinical Outcomes of Percutaneous Left-Atrial Appendage Occlusion with Conscious Sedation without an Anesthesiologist on Site: Results from a Multicenter Study

Matteo Bianco et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Percutaneous left-atrial appendage (LAA) occlusion is an important therapeutic option for preventing cardioembolic stroke in patients with non-valvular atrial fibrillation (AF) at high risk of thromboembolic events and with contraindications for oral anticoagulation (OAC). It is usually performed with transesophageal echocardiography (TOE) guidance under general anesthesia (GA). In this retrospective study, we present a multicenter experience of LAA occlusion performed with conscious sedation (CS) without an anesthesiologist on site. Materials and Methods: All the patients on the waiting list for LAA occlusion procedure at Infermi Hospital, Rivoli, and San Luigi Gonzaga University Hospital, Orbassano, from October 2018 to October 2022 were analyzed. All the procedures were performed with a Watchman/FLX LAA closure device under TOE and fluoroscopic guidance without an anesthesiologist on site. CS was performed with a combination of midazolam and fentanyl as needed. Results: One-hundred fifteen patients were included (age 76.4 ± 7.6 years, median CHA2DS2Vasc 4.4 ± 1.4). CS was performed using midazolam (mean dose 5.9 ± 2.1 mg), adding fentanyl for thirty-nine (33.9%) patients in case of poor tolerance for the procedure despite midazolam. The acute procedural success rate was 99.1%. We observed seven acute severe complications. No patients needed anesthesiological assistance during the procedure, and no cases of respiratory failure necessitating ventilation were reported. In a follow-up after 10 ± 9 months, one case of stroke (0.9%) and one case (0.9%) of transient ischemic attack (TIA) occurred. Conclusions: LAA occlusion performed under CS and without the presence of an anesthesiologist on site appears to be safe and effective. It can be an attractive alternative to general anesthesia (GA), as fewer resources are required.

Keywords: anesthesia; left atrial appendage; left atrial appendage occlusion; sedation; transesophageal echocardiography.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The team present in the cath-lab during LAA occlusion procedure with CS without anesthesiologist on site.
Figure 2
Figure 2
Flow chart of patients included in the analysis.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Chugh S.S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E.J., Gillum R.F., Kim Y.H., McAnulty J.H., Jr., Zheng Z.J., et al. Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2014;129:837–847. doi: 10.1161/CIRCULATIONAHA.113.005119. - DOI - PMC - PubMed
    1. Lip G.Y., Andreotti F., Fauchier L., Huber K., Hylek E., Knight E., Lane D.A., Levi M., Marin F., Palareti G., et al. Bleeding risk assessment and management in atrial fibrillation patients: A position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace. 2011;13:723–746. doi: 10.1093/europace/eur126. - DOI - PubMed
    1. Hylek E.M., Evans-Molina C., Shea C., Henault L.E., Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation. 2007;115:2689–2696. doi: 10.1161/CIRCULATIONAHA.106.653048. - DOI - PubMed
    1. Collado F.M.S., Lama von Buchwald C.M., Anderson C.K., Madan N., Suradi H.S., Huang H.D., Jneid H., Kavinsky C.J. Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation. J. Am. Heart Assoc. 2021;10:e022274. doi: 10.1161/JAHA.121.022274. - DOI - PMC - PubMed
    1. Whitlock R.P., Belley-Cote E.P., Paparella D., Healey J.S., Brady K., Sharma M., Reents W., Budera P., Baddour A.J., Fila P., et al. Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. N. Engl. J. Med. 2021;384:2081–2091. doi: 10.1056/NEJMoa2101897. - DOI - PubMed

Publication types